Dossier

Opioïdes

Le droit des opioïdes détermine comment les gouvernements répondent à la crise des surdoses : comment les sommes des règlements sont dépensées, où la naloxone et le traitement sont offerts et comment le trafic de fentanyl est poursuivi. Suivez les projets de loi sur le traitement, la réduction des méfaits, les règlements et l’application de la loi.

Projets de loi sur les opioïdes

Résultats en direct pour « opioids » dans toutes les régions couvertes, provenant de la même recherche que celle du site.

S4935

New Jersey

Expands oversight and transparency of funds received by State and local entities due to national opioid settlements.

Bill S-4935. Sponsored by Paul Moriarty (Democratic).

A5722

New Jersey

Requires hotels and harm reduction service providers to cooperate in providing opioid antidotes and harm reduction supplies at hotels.

Bill A-5722. Sponsored by Aura Dunn (Republican).

Projet de loi 54

Northwest Territories

An Act to Amend the Opioid Damages and Health Care Costs Recovery Act

Bill 54, An Act to Amend the Opioid Damages and Health Care Costs Recovery Act, bill would give the Government of Canada the right to sue opioid-related manufacturers, wholesalers and consultants to recover health care costs, including aggregate claims with anonymized records. It is at 2nd Reading as of October 23, 2026. Sponsored by Jay MacDonald.

S.2072

United States

MORE Savings Act

Bill S-2072, MORE Savings Act, removes cost-sharing for certain opioid treatments and recovery services in Medicare and many health plans. It is at Read twice and referred to the Committee on Finance. as of June 12, 2025.

H.R.1257

United States

OPIOIDS Act

Bill HR-1257, OPIOIDS Act, would support overdose data, forensic testing, drug tracking, and training for first responders and law enforcement. It is at Referred to the House Committee on the Judiciary. as of February 12, 2025.

H.R.10649

United States

Safe Disposal of Opioids Act

Bill HR-10649, Safe Disposal of Opioids Act, creates grants for medication disposal sites and a fee on opioid sales, with discounts for eligible patients. It is at Introduced as of October 1, 2026. Sponsored by Suzanne Bonamici (D) and Riley Moore.

H.R.10678

United States

Expands grants for fentanyl testing tools

Bill HR-10678, Expands grants for fentanyl testing tools, the bill would let certain grant funds be used to buy fentanyl testing kits and overdose reversal drugs. It is at Introduced as of October 1, 2026. Sponsored by Thomas Kean (R), Jefferson Van Drew, Andrew Garbarino, and Michael Lawler.

S.1975

United States

Dark Web Interdiction Act

Bill S-1975, Dark Web Interdiction Act, creates a dark-web drug offense, a federal task force, required reports, and a sentencing guideline increase to combat opioid distribution on dark web marketplaces. It is at Read twice and referred to the Committee on the Judiciary. as of June 5, 2025.

H.R.8000

United States

END 7-OH Act

Bill HR-8000, END 7-OH Act, adds synthetic 7-hydroxymitragynine to Schedule I, excluding the compound when naturally in kratom (Mitragyna speciosa). It is at Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of March 19, 2026.

H.Res.1503

United States

Supporting Overdose Awareness Day

Bill HRES-1503, Supporting Overdose Awareness Day, house resolution recognizing Overdose Awareness Day and urging action to reduce stigma, support prevention, treatment, harm reduction, and recovery from opioid use disorder. It is at Referred to the House Committee on Energy and Commerce. as of August 31, 2026.

H.R.10037

United States

Virtual opioid treatment for veterans

Bill HR-10037, Virtual opioid treatment for veterans, a VA pilot to expand telehealth-based opioid treatment for veterans, combining counseling and medication, coordinating with community providers, plus a study on barriers, over a two-year period. It is at Referred to the Subcommittee on Health. as of August 10, 2026.

S.Res.369

United States

Fentanyl Prevention and Awareness Day

Bill SRES-369, Fentanyl Prevention and Awareness Day, designates August 21, 2025, to remember fentanyl victims and promote awareness, prevention, and drug-free choices. It is at Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S5520; text: CR S5516) as of August 2, 2025.

S.Res.95

United States

National Fentanyl Awareness Week

Bill SRES-95, National Fentanyl Awareness Week, designates Feb 23–Mar 1, 2025 as a week to raise awareness about fentanyl harms and responses. It is at Referred to the Committee on the Judiciary. (text: CR S1358) as of February 25, 2025.

H.R.8005

United States

Counterfeit Pill Prohibition Expansion

Bill HR-8005, Counterfeit Pill Prohibition Expansion, expands federal prohibition to include fentanyl and counterfeit pills, requires a DEA operation plan, audits campaigns, and annual data reports to Congress on seizures and enforcement. It is at Received in the Senate and Read twice and referred to the Committee on the Judiciary. as of September 16, 2026.

PR26-0793

District of Columbia

Bill would extend outreach grants amid crisis

Bill PR26-0793, Bill would extend outreach grants amid crisis, the DC Council would extend current FY2026 outreach grants using the Opioid Abatement Fund until a permanent program starts. It is at Resolution R26-0515, Effective from Sep 22, 2026 Published in DC Register Vol 73 and Page 012782 as of October 2, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.

B26-0792

District of Columbia

Behavioral Health Grants Extended

Bill B26-0792, Behavioral Health Grants Extended, department would renew Fiscal Year 2027 grants for former FY2026 recipients in Wards 1, 2, 5, and 6, funded by the Opioid Abatement Fund. It is at Transmitted to Mayor, Response Due on November 9, 2026 as of October 9, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, who voted for it, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.

B26-0791

District of Columbia

Extend outreach grants for substance use services

Bill B26-0791, Extend outreach grants for substance use services, the bill would extend 90-day outreach grants for substance-use services in Wards 1, 2, 5, and 6, reissuing FY2026 grants if funds are available. It is at Returned from Mayor as of October 20, 2026. Sponsored by Brianne Nadeau (Democratic), who voted for it, Brooke Pinto, who voted for it, Trayon White, Elissa Silverman, who voted for it, Zachary Parker, who voted for it, and Phil Mendelson, who voted for it.

H.R.7970

United States

Nitazenes Schedule I designation

This measure would permanently place nitazene opioids in Schedule I, tightening federal controls and affecting researchers, manufacturers, and enforcement efforts.

H.R.6407

United States

RCORP Authorization Act

Maintains and funds a rural opioid prevention, treatment, and recovery grant program run by HRSA.

S.3076

United States

Nitazene Control Act

Permanently places nitazene-class synthetic opioids into Schedule I of the Controlled Substances Act.

Voir tous les projets de loi →Chargement des projets de loi.